Wall Street Falters Again on Tuesday

Wall Street was lower again on Tuesday while traders fretted over a delay in organizing a crucial installment of bailout money for Greece and the approaching “fiscal cliff” in the United States.

The Dow Jones Industrials dumped 58.90 points to finish the session at 12,756.20.

The S&P 500 staggered 5.50 points to 1,374.53, and the Nasdaq Composite Index withered 20.37 points to 2,883.89.

Lawmakers are trying to strike a deal that prevents the onset of sharp spending cuts and tax increases in January. President Obama plans to meet with union leaders on Tuesday, a number of business leaders on Wednesday and then Congressional leaders on Friday.

Windows chief Steven Sinofsky, heir apparent to Microsoft CEO Steve Ballmer, left the company late Monday. Sinofsky had been at Microsoft since 1989, trusted with overseeing many of the company’s core products — including Office and the recent Windows 8 debut.

Shares of Dow component Home Depot rose after the company beat sales and earnings forecasts. The nation’s largest homebuilding supply retailer raised its guidance for the current quarter, and said it’s seeing a beginning in the “healing of the housing market.”

Dick’s Sporting Goods beat analyst expectations on both income and revenue and raised its guidance for fourth-quarter sales. Michael Kors Holdings reported quarterly earnings and revenue that beat expectations.

Meanwhile, Monster Beverage shares were up 2% after the company announced plans to repurchase up to $250 million U.S. worth of its own common stock.

Saks reported earnings in line with forecasts but fell short on revenue. The retailer lowered its sales guidance for the fourth quarter, citing disruptions from Hurricane Sandy.

Shares of TJX rose after the parent of T.J. Maxx and Marshalls reported that third-quarter sales and earnings rose.

After the bell, Cisco Systems will release its results.

Economically speaking, the Treasury Department reported a larger-than-expected deficit of $119.9 billion U.S. for October, compared with an expected shortfall of $113 billion U.S.

The price on the benchmark 10-year U.S. Treasury gained ground early Tuesday, lowering yields to 1.59% from Friday’s 1.61%. Treasury prices and yields move in opposite directions.

Oil prices surrendered 30 cents to $85.31 U.S. a barrel.

Gold prices dropped $5.90 an ounce to $1,725.20 U.S.

Dow Jones Industrial Average (DJIA) Stock Quote and News:

Disclaimer: Neither www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/about-2/disclaimer.

0 comments

Add your comment

Commenting is allowed only for registered users.

Other articlesgo to homepage

	Ecosphere Delivers Two More Ozonix Water Treatment Units to Hydrozonix(0) Ecosphere Technologies, Inc. (OTCBB: ESPH) said Monday that it delivered two more Ozonix EF80 units to Hydrozonix LLC as part of a long-term contract with water treatment solutions company. Hydrozonix is a strategic alliance of a consortium of the principals at Phillips and Jordan, Inc., the Siboney Group and PBA Holdings that provides mobile, eco-friendly

	Glaxo Genital Herpes Vaccine Flops but Genocea a Buy in Vaccine Space(0) By Rex Graham A Glaxo Smith Kline (GSK) genital herpes vaccine recently flopped in a large clinical trial, but “next generation” genital herpes vaccines by Genocea Biosciences, Agenus, Inc. (AGEN), Vical, Inc. (VICL), and Sanofi Pasteur (SNY) offer new hope for an effective vaccine treatment. A Yale University study published in the Nov. 15, 2012,

	Senate Approves Tax Hikes and Delay in Spending Cuts(0) Technically, the United States has gone over the fiscal cliff with January 1 arriving before a new budget was passed to avert a series of automatic tax increases and deep spending cuts. But, the Senate said Tuesday morning that the White House and Senate Republicans have come to terms to raise taxes on households bringing-in

	ALR Technologies Names Former Pfizer Exec as Chief Commercial Officer(0) Health information company ALR Technologies, Inc. (OTCBB: ALRT) on Monday disclosed the appointment of William S. Smith as Chief Commercial Officer and member of the Board of Directors, effective January 1, 2013. Smith will oversee sales and marketing, investor relations, public affairs, communications and government affairs, according to a corporate statement. Previously, Smith spent ten

	Cellceutix Enters $10 Million Share Purchase Agreement, Shares Jump(0) Cellceutix Enters Into a $10 Million Common Stock Purchase Agreement With Aspire Capital Fund, LLC Cellceutix Corporation (OTCBB: CTIX) (the “Company”), a clinical stage biopharmaceutical company focused on discovering small molecule drugs to treat unmet medical conditions, including drug-resistant cancers and autoimmune diseases, today announced that it has entered into a common stock purchase agreement

Stay Informed

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.